Also, previous evidence reported an upregulation of SOCS3 mRNA levels in fibroblast-activated macrophages accumulated in pulmonary arterioles from IPAH patients and a parallel upregulation of IL-6/STAT3 axis suggesting a potential drug target [31]. The gene discussed is IL6; the disease is idiopathic pulmonary arterial hypertension.